America's Specialty Medicine Companies
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of America's Specialty Medicine Companies
Names of Lobbyists
Most Frequently Disclosed Lobbying Issues
- Copyright, Patent & Trademark,
- Health Issues
Most Frequently Disclosed Bills
Bill No. Title H.R.2 Repealing the Job-Killing Health Care Law Act H.R.1249 America Invents Act S.23 Patent Reform Act of 2011 S.27 Preserve Access to Affordable Generics Act S.319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2632 Life Sciences Jobs and Investment Act of 2011 H.R.2672 Preserving Access to Orphan Drugs Act of 2011 H.R.2674 340B Program Improvement Act S.340 Airport and Airway Trust Fund Reauthorization Act of 2011 S.1410 Life Sciences Jobs and Investment Act of 2011